Corrigendum: Mechanism of early dissemination and metastasis in Her2

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA.Breast cancer research : BCR · 2023
   Article
2. Transcriptome Analysis Reveals Key Genes and Pathways Associated with Metastasis in Breast Cancer.OncoTargets and therapy · 2020
   Article
3. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.Frontiers in molecular biosciences · 2020
   Article
4. Metastatic Latency, a Veiled Threat.Frontiers in immunology · 2019
   Review
5. Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells.Biology open · 2018
   Article

Corrections and comments

• Erratum for
  Mechanism of early dissemination and metastasis in Her22016

Authors and funding

14 authors.

Funding

Abstract